Increased expression of KRT14 is negatively associated with progression-free survival and response to therapy in ovarian cancer patients [11], and KRT14+ cells are also enriched in chemo-resistant bladder cancer [12]. This evidence concerns the gene KRT14 and ovarian carcinoma.